Aging Well Together - 'Getting to Know You Better': Characterization of Health FACTors in People Advancing in AGE

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorCentre Hospitalier Universitaire de Nice

About this trial

In order to implement effective actions to prevent the loss of autonomy in older adults, which has become a major issue, a crucial first step is to identify the conditions that influence it. Current approaches to health increasingly rely on a comprehensive and multidisciplinary vision, in line with so-called "socio-ecological" approaches, which argue that health is influenced by a wide range of interacting factors. However, these interdependencies and interactions are still poorly understood. It therefore seems necessary to move beyond the isolated analyses of risk factors carried out to date and adopt a holistic/systemic vision by examining both individual and environmental factors, as well as their interactions, which together can contribute to functional decline or the development of pathologies in older adults and those aging.

The aim of this study is to identify the relationships between intrapersonal and environmental factors, and their cumulative, moderating, and mediating effects on the health of older adults and those experiencing aging.

To this end, participants will be asked to complete a series of questionnaires and perform tests on various health-related dimensions. The evaluation criteria are: health, autonomy and quality of life, individual factors (health practices (e.g., physical activity), psychological characteristics (e.g., personal beliefs), socioeconomic status, etc.) and environmental factors (accessibility, living environment).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 55 or older

Affiliation with, or beneficiary of, a social security system

No objection to the study

Disqualifiers

Individuals protected by law

unable to participate in a clinical trial

deprived of liberty

Trial design

Design model

Single group

Treatments tested in this trial

  • Questionnaire and Physical Exam

    Other intervention

    Questionnaires and tests on health behaviors and health

Treatment groups

4,500 Participants
are divided into 1 treatment group
Group A: FACTAGEExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Autonomy

Autonomy is assessed using the Instrumental Activities of Daily Living (IADL) Scale of Lawton. The scale comprises 8 items. The total score ranges from 0 to 8, with a higher score being better.

Time frame
at baseline and at 6 months and at 12 months

Secondary outcomes

1

Care consumption, health behavior and psycho-socio-environmental characteristics

The evaluation criteria will be, on the one hand, the same individual and environmental factors (e.g., personal beliefs, socio-economic status, accessibility, physical activity, diet) mentioned previously for the main objective, and on the other hand, the consumption of care (number and types of care).

Time frame
at baseline and at 6 and 12 months
2

Measure Quality of life

Quality of life is assessed using the EuroQol at 5 dimensions (EQ-5D) questionnaire. The scale comprises 5 items. Each item is scored from 1 "no problem" to 3 "severe problem". The total score ranges from 5 to 15 with higher score indicating a worse outcome.

Time frame
at baseline and at 6 months and at 12 months
3

Physical functional force (physical measure)

: Physical functional force is assessed using the 5 sit-to-stand test wich consists of asking the participant to stand up and sit down from a chair 5 times as quickly as possible. The outcome is the time taken to complete the test, and the unit of measurement is seconds.

Time frame
at baseline and at 6 months and at 12 months
4

Sarcopenia (physical measure)

Sarcopenia is assessed using the SARC-F questionnaire comprising 5 items assessing force, walk difficulties, stand up capacities, climb stairs capacities and fall. Each item is scored from 0 to 2. The total score ranges from 0 to 10 with higher score indicating a worse outcome.

Time frame
at baseline and at 6 months and at 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: